Murdoch et al., British Journal of General Practice, 2019
A practical guide written for family doctors by five clinicians.
What it found. Sulfonylureas and insulin usually need to be reduced or stopped when a patient cuts carbs, because blood glucose typically falls substantially. SGLT2 inhibitors carry a risk of ketoacidosis that can occur with normal blood glucose. Metformin, GLP-1 drugs and DPP-4 inhibitors pose no excess risk, and blood pressure medication may need adjusting too.
The limits. It is guidance for prescribers, based on clinical experience and how the drugs work, not a trial. It is not a set of instructions for patients.




